MusclePharm Corp
OTC:MSLPQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MusclePharm Corp
Total Liabilities & Equity
MusclePharm Corp
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MusclePharm Corp
OTC:MSLPQ
|
Total Liabilities & Equity
$11.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Total Liabilities & Equity
$19.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
9%
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Total Liabilities & Equity
$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Total Liabilities & Equity
$11.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Total Liabilities & Equity
$1.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Total Liabilities & Equity
$2.3B
|
CAGR 3-Years
61%
|
CAGR 5-Years
37%
|
CAGR 10-Years
20%
|
|
MusclePharm Corp
Glance View
MusclePharm Corp. engages in the development, manufacture, and distribution of branded sports nutrition products and nutritional supplements. The company is headquartered in Burbank, California. The company went IPO on 2008-12-03. The firm develops, manufactures, markets and distributes branded sports nutrition products and nutritional supplements. The firm's portfolio of brands includes MusclePharm and FitMiss. The MusclePharm brand product portfolio is designed for athletes of all levels and anyone who pursues an active lifestyle. The company offers a range of performance powders, capsules, tablets and gels. Its portfolio of products targets every type of fitness enthusiast and professional, from combat sport, weight training, bodybuilding, running, and all team and individual sports, as well as individuals who lead an active lifestyle. Its offerings are clinically developed through a six-stage research process. The company provides its products under various categories, such as Sport Series, Essentials Series, Natural Series, FitMiss and On-the-Go. Its retail distribution channels include specialty, international and food, drug, and mass (FDM).
See Also
What is MusclePharm Corp's Total Liabilities & Equity?
Total Liabilities & Equity
11.2m
USD
Based on the financial report for Dec 31, 2021, MusclePharm Corp's Total Liabilities & Equity amounts to 11.2m USD.
What is MusclePharm Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 1Y
-14%
Over the last year, the Total Liabilities & Equity growth was -14%.
